Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $29.49 -2.16%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Baird analyst Joel Beatty raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $52.00 (from $28.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR140 at Citi
- HCL Technologies (HCLT:IN) PT Lowered to INR1,030 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
